iSpecimen Inc (ISPC)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $1.66M
Last updated: Nov 17, 2026 at 11:04 AM ET
Performance (10Y)
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 42.5% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 22.4, below 30, the oversold line.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about ISPC
News
ISPC Valuation
ISPC Profitability: Margins, ROIC and FCF
iSpecimen (ISPC) has a gross margin of -108.3%, an operating margin of -2020.0% and a net margin of 0.0%. It posts a -1866.6% FCF margin.
- Gross margin
- -108.3%
- Operating margin
- -2020.0%
- Net margin
- 0.0%
- ROE
- -968.0%
- FCF margin
- -1866.6%
iSpecimen Competitors
The companies most similar to iSpecimen (ISPC) include bioAffinity Technologies, XWELL and Exagen.
Sector: Healthcare
Companies most similar to iSpecimenISPC Bull Case vs Bear Case
Bear case
- ISPC beat EPS estimates in 37.5% of its last 8 reported quarters.
- ISPC's quarterly revenue changed -78.7% year over year.
ISPC Earnings: Beat Rate
iSpecimen (ISPC) beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate (37.5%).
- Beat rate
- 3 of 8 quarters (37.5%)
- Average surprise
- -93.9%
ISPC ETF Holders
GNG tracks 1 ETF that holds ISPC.
- Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
Updated Aug 14, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About ISPC
Does ISPC pay dividends?
iSpecimen Inc (ISPC) does not currently pay a regular dividend.
What is ISPC's market cap?
iSpecimen Inc (ISPC) has a market capitalization of $1.66M with a current stock price of $0.60.
ISPC pages: Overview, Earnings, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.